CSIMarket
 
Aclaris Therapeutics Inc   (NASDAQ: ACRS)
 

Aclaris Therapeutics Inc's Customers Performance

ACRS



 
ACRS's Source of Revenues During the corresponding time, Aclaris Therapeutics Inc saw a revenue deteriorated by -8.33 % year on year, sequentially revenue fell by -18.39 %. While revenue at the Aclaris Therapeutics Inc 's corporate clients

List of ACRS Customers




for the same period Aclaris Therapeutics Inc revnue deteriorated by -8.33 % year on year, sequentially revenue fell by -18.39 %.

List of ACRS Customers

Aclaris Therapeutics Inc's Business Units
Licensing revenue Single reportable segment    54.82 % of total Revenue
License and Service    167.71 % of total Revenue
Single reportable segment    222.53 % of total Revenue






Aclaris Therapeutics Inc's Comment on Sales, Marketing and Customers



The company operates within a regulatory environment governed by laws such as the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Affordable Care Act, and various state regulations. Its market segments include federal health care benefit programs, private third-party payors, Medicaid, other state programs, physicians (including doctors, dentists, optometrists, podiatrists, and chiropractors), other health care professionals (such as physician assistants and nurse practitioners), and teaching hospitals. The company adheres to compliance requirements concerning payments and transfers of value to these healthcare professionals and institutions.





Aclaris Therapeutics Inc’s Comment on Sales, Marketing and Customers


The company operates within a regulatory environment governed by laws such as the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Affordable Care Act, and various state regulations. Its market segments include federal health care benefit programs, private third-party payors, Medicaid, other state programs, physicians (including doctors, dentists, optometrists, podiatrists, and chiropractors), other health care professionals (such as physician assistants and nurse practitioners), and teaching hospitals. The company adheres to compliance requirements concerning payments and transfers of value to these healthcare professionals and institutions.








ACRS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Aclaris Therapeutics Inc 755.14 8.37 -69.66 73
SUBTOTAL 0.00 0.00 0.00 -

Sources: Aclaris Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Aclaris Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Aclaris Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.